Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Analgesic Efficacy and Safety of a New Analgesic Compared to Placebo in Subjects With Painful Diabetic Peripheral Neuropathy

NCT01056315 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT01056315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01056315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Analgesic Efficacy and Safety of a New Analgesic Compared to Placebo in Subjects With Painful Diabetic Peripheral Neuropathy
Lead sponsor
Grünenthal GmbH
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2009
Completion date
January 31, 2011
Enrollment
553 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

painful diabetic neuropathy